Alpha-pinene

Alpha-Pinene: A Comprehensive Reference Article

1. Identity and Chemical Profile

Names and Classification

Alpha-pinene (α-pinene) is an organic compound of the terpene class and one of the two isomers of pinene, the other being β-pinene. It is a naturally derived monoterpene hydrocarbon. Its systematic IUPAC name is (1S,5S)-2,6,6-trimethylbicyclo[3.1.1]hept-2-ene, and it is registered under CAS number 80-56-8. The molecular formula is C₁₀H₁₆. As an alkene, it contains a strained four-membered ring. Other synonyms include DL-pin-2(3)-ene and 2-pinene.

Enantiomers

Both enantiomers are known in nature: (1S,5S)- or (−)-α-pinene is more common in European pines, whereas the (1R,5R)- or (+)-α-isomer is more common in North America. The enantiomers' racemic mixture is present in some oils such as eucalyptus oil and orange peel oil. The two enantiomeric forms have been observed to exhibit slightly different biological activity profiles; in vitro assays have shown an enantioselective profile of (+)- and (−)-α-pinene for antibacterial and insecticidal activity, respectively.

Natural Sources

α-Pinene occurs naturally in a variety of trees and shrubs, including more than 400 essential oils, and air concentrations near pine forests may reach 500–1200 mg/m³. It is found in the oils of many species of coniferous trees, notably Pinus and Picea species. It is also found in the essential oil of rosemary (Rosmarinus officinalis) and Satureja myrtifolia. α- and β-pinene are mainly produced by pine trees and many other conifers, as well as a wide range of herbs such as rosemary, parsley, basil, and even orange peel. It is a primary component of gum turpentine and is widely found in over 400 types of natural essential oils, including those from pine, fir, eucalyptus, rosemary, sage, and frankincense.

α-Pinene is the most abundant terpene in nature and is obtained industrially by fractional distillation of turpentine. (+)-α-Pinene occurs in the oil of Pinus palustris Mill. at concentrations of up to 65% and in the oil of Pinus caribaea at concentrations of 70%; P. caribaea also contains (−)-α-pinene at concentrations of 70–80%. α-Pinene, as the most abundant monoterpene in the atmosphere, accounts for more than 50% of global monoterpene emissions and is a major component of phytoncides. Phytoncides are antimicrobial allelochemical volatile organic compounds related to forest healing and activation of recreational forests, with trees considered one of the major emitters.

Common Forms and Preparations

Alpha-pinene is mainly obtained by natural means through fractional distillation of turpentine essential oil, of which it is the major compound by far. Large-scale production typically involves the fractional distillation of turpentine oil, which separates the mixture into its individual chemical components, yielding high-purity alpha-pinene. In commercial and research contexts, α-pinene is available as:

• Isolated liquid terpene: High-purity α-pinene obtained by fractional distillation, used as a flavoring additive, fragrance ingredient, or pharmaceutical-grade research compound.
• Essential oils: Pine needle oil, rosemary oil, and numerous other plant essential oils contain α-pinene as a major or significant constituent, and these are used in aromatherapy, food flavoring, and cosmetics.
• Terpene-containing dietary supplements: α-Pinene appears as a constituent of multi-terpene botanical preparations, including cannabis terpene isolates and pine bark extracts.
• Aroma/inhalation preparations: Used in forest therapy (shinrin-yoku), diffusers, and inhalation studies.

α-Pinene is used as a safe food additive and is contained in many essential oils. Exposure to α-pinene via a normal diet is estimated at 317 μg/day.

2. Traditional and Historical Use

The distillation of turpentine oil from pine resin, and the subsequent isolation of α-pinene, dates back to the 19th century with the rise of industrial chemistry in Europe; however, its presence and use predate this by centuries through the folk use of pine resins and oils in traditional medicine and incense.

Even though the pinene scaffold is abundant in nature and has historical use in traditional medicine, pinene and pinene-derived compounds have not been comprehensively studied for medicinal applications. Some effects were uncovered through the study of active ingredients in the plants used in traditional Chinese medicine. Pine needle oil from crude extract of pine needles has been used as an anti-cancer agent in Traditional Chinese Medicine.

Bursera morelensis, a tree endemic to Mexico, has been traditionally used for the treatment of skin wounds; the people of San Rafael, Coxcatlan (Puebla, Mexico), make a tea with the bark of this species to wash wounds, and it has been verified that the essential oil of this plant acts as an anti-inflammatory compound with antimicrobial and antifungal activity.

In traditional healing practices across multiple cultures, plants rich in α-pinene were prepared and used in several ways:

• Pine resin and bark scraping: Traditional healers would scrape bark or pine resin from coniferous trees as an easy source of α-pinene.
• Respiratory uses: α-Pinene has been used to treat respiratory tract infections for centuries.
• Antiseptic and wound care: Turpentine-derived preparations, of which α-pinene is the primary constituent, were historically applied externally as topical antiseptics.
• Traditional Chinese Medicine (TCM): Some pharmacological effects of pinenes were uncovered through the study of active ingredients in the plants used in traditional Chinese medicine; for example, a 2011 study showed that alpha-pinene derivatives isolated from Angelica sinensis inhibited platelet aggregation.

3. Key Constituents, Chemistry, and Mechanisms of Action

Chemical Structure

α-Pinene is an organic compound of the terpene class and, as an alkene, contains a strained four-membered ring. Its systematic name is (1RS,5RS)-2,6,6-trimethylbicyclo[3.1.1]hept-2-ene; it is a monoterpene found in coniferous trees and plants such as Piper nigrum and Cannabis sativa L. It tends to react with other chemicals, forming a variety of other terpenes (like limonene), as well as other compounds.

Anti-Inflammatory Mechanisms

α-Pinene exhibits anti-inflammatory activity through the suppression of mitogen-activated protein kinases (MAPKs) and the nuclear factor-kappa B (NF-κB) pathway in mouse peritoneal macrophages. In LPS-stimulated macrophages, α-pinene significantly decreased the LPS-induced production of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and nitric oxide (NO), and also inhibited inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expressions; additionally, the activations of MAPKs and NF-κB were attenuated by α-pinene treatment.

As a potent antioxidant, it inhibits prostaglandin E1 and NF-κB, thereby contributing to reported anti-inflammatory and anti-carcinogenic effects. The anti-inflammatory impact of α-pinene in hepatocytes may be strongly linked to the suppression of NF-κB; the preventive effect of α-pinene in high-glucose-induced lipid peroxidation has been associated with a reduction in the production of lipid mediators, including prostaglandins, which play a crucial role in the inflammatory response.

Cholinergic and Neuroprotective Mechanisms

α-Pinene is highly bioavailable, with 60% human pulmonary uptake and rapid metabolism or redistribution; it is anti-inflammatory via PGE1, and exhibits activity as an acetylcholinesterase inhibitor, aiding memory. The memory-improving effect of alpha-pinene may be mediated by its effect on cholinergic neurotransmission; in particular, α-pinene has a therapeutic effect on Alzheimer's disease by inhibiting acetylcholinesterase, an enzyme involved in the breakdown of acetylcholine, and α-pinene treatment also increases the mRNA expression of choline acetyltransferase, an enzyme that catalyzes the production of acetylcholine.

Research has also shown that α-pinene acts as a partial modulator of GABA_A-benzodiazepine receptors and enhances GABAergic synaptic transmission directly by binding to the benzodiazepine-binding site of the GABA_A receptor. It enhances the duration of non-rapid eye movement sleep, predominantly via the activation of GABA_A receptors; moreover, α-pinene has anti-acetylcholinesterase activity, which may result in increased acetylcholine transmission, a critical neurotransmitter for facilitating learning and memory.

Anxiolytic and Antidepressant Mechanisms

α-Pinene exerts its antidepressant and anxiolytic effects through 5-HT1A, β-Adrenergic, and D1 receptors while also enhancing hippocampal BDNF and dopamine synthesis, both of which are critical factors in the pathogenesis of depression and anxiety.

Antimicrobial Mechanisms

α-Pinene has been used as an antibiotic resistance modulator for Campylobacter jejuni, acting on antibacterial resistance modulation and the prevention of antimicrobial efflux; it was able to modulate antibiotic resistance considerably by reducing the MIC value of ciprofloxacin, erythromycin, and triclosan by up to 512 times, and ethidium bromide accumulation experiments suggested that α-pinene targets antimicrobial efflux systems.

Anticancer Mechanisms

The naturally occurring compound α-pinene induces cell cycle arrest and antitumor activity; in HepG2 hepatocellular carcinoma cells, α-pinene treatment resulted in dose-dependent growth inhibition as a result of G2/M-phase cell cycle arrest, associated with down-regulated cyclin-dependent kinase 1 (CDK1) and miR-221 levels and up-regulated levels of CDKN1B/p27, γ-H2AX, phosphorylated ATM, phosphorylated Chk2, and phosphorylated p53. These observations are consistent with a model in which α-pinene inhibits miR-221 expression, which leads to G2/M-phase arrest and activation of CDKN1B/p27-CDK1 and ATM-p53-Chk2 pathways that suppress human hepatoma tumor progression.

4. Scientific Evidence by Area of Use

4.1 Inflammation and Joint Health

The most extensively studied area for α-pinene is inflammation. In vitro research has demonstrated that α-pinene exhibits anti-inflammatory activity through the suppression of MAPKs and the NF-κB pathway in mouse peritoneal macrophages.

A study published in Journal of Natural Products (2014, PubMed PMID 24455984) used human chondrocyte cell models of osteoarthritis. The data obtained showed isomer- and enantiomer-selective anti-inflammatory and anticatabolic effects of α-pinene in human chondrocytes, with (+)-α-pinene being the most promising for further studies to determine its potential value as an antiosteoarthritic drug.

The protective effects of α-pinene in acute pancreatitis were studied by Bae et al., who observed that pretreatment with α-pinene (intraperitoneal administration) reduced histological damage and myeloperoxidase activity in the pancreas and lungs of cerulein-induced acute pancreatitis in laboratory rats; mechanistic studies showed neutralized production of pancreatic TNF-α, IL-1β, and IL-6.

A 2022 study in rodents investigated liver fibrosis. Alpha-pinene is a monoterpene found in coniferous trees and plants such as Piper nigrum and Cannabis sativa L., and has been shown to be anti-oxidant, anti-inflammatory, anti-apoptotic, anti-diabetic, cardioprotective, and neuroprotective. Researchers examined alpha-pinene in adult male Wistar rats to determine whether it affects oxidative and nitrosative stress, inflammation, liver enzyme levels, collagen and MMP2 expression, and histological changes resulting from CCl₄ treatment, studying the TLR4/NF-κB, TGF-β/Smad2/3, and PI3K/Akt/mTOR signaling pathways.

Evidence strength: The anti-inflammatory evidence for α-pinene is predominantly from in vitro cell studies and animal models. There are no robust, controlled human clinical trials specifically testing isolated α-pinene as an anti-inflammatory agent in humans. Evidence is preliminary.

4.2 Respiratory Health and Bronchodilation

α-Pinene is a bronchodilator in humans and has anti-inflammatory properties via the prostaglandin E-1 pathway. Alpha-pinene was studied in 2011 for its effects on the human respiratory system through inhalation; researchers found that low concentrations of inhaled α-pinene resulted in an airway-dilating effect, suggesting it may have a beneficial effect for people with asthma.

Evidence strength: Human data on bronchodilatory effects from inhalation exists but is limited in scope and study size. Broader clinical trials are lacking. The bronchodilatory mechanism is plausible given α-pinene's prostaglandin pathway activity, but this remains an area requiring further controlled investigation.

4.3 Neurology and Cognitive Function

Multiple preclinical animal studies have investigated the effects of α-pinene on cognition and neurological protection.

A 2017 study published in Evidence-Based Complementary and Alternative Medicine (PMC5687139) used C57BL/6 mice with scopolamine-induced memory impairment. The researchers investigated the neuroprotective effect of α-pinene against learning and memory impairment induced by scopolamine (1 mg/kg, i.p.), a muscarinic receptor antagonist; administration of α-pinene (10 mg/kg, i.p.) significantly improved scopolamine-induced cognitive dysfunction as assessed by Y-maze and passive avoidance tests, and in the Morris water-maze test, α-pinene effectively shortened the mean escape latency to find the hidden platform during training days.

Studies have shown that α-pinene improves avoidance memory and motor activity in a rat model of Parkinson's disease via neuroprotective effects against 6-hydroxy dopamine toxicity and by reducing oxidative damage. It has also been reported that α-pinene inhalation enhances BDNF gene expression in the olfactory bulb and hippocampus in mice.

A 2023 study in Frontiers in Molecular Neuroscience found that alpha-pinene pre- and post-treatment moderated memory impairment induced by kainic acid by restoring the BDNF/TrkB/CREB signaling pathway in the rat hippocampus.

Regarding ischemia, results demonstrated that NF-κB p65, iNOS, and COX-2 gene and protein expression increased in the hippocampus, cortex, and striatum after 24 h of reperfusion, and alpha-pinene significantly inhibited NF-κB p65, iNOS, and COX-2 expression. In that study, male Wistar rats underwent MCAO surgery for 1 h and different doses of alpha-pinene (25, 50, and 100 mg/kg) were intraperitoneally injected immediately after reperfusion.

Evidence strength: All available evidence on cognitive and neuroprotective effects is from animal models only. No controlled human trials have been conducted for α-pinene's effects on cognition, Alzheimer's disease, or Parkinson's disease.

4.4 Anxiety and Depression

Alpha-pinene is a natural and active monoterpene found in coniferous tree oil, primarily pine, with diverse pharmacological characteristics, including antioxidative, anxiolytic, and antidepressant properties. Results from the Open Field Test (OFT) indicated that ketamine administration induced anxiety-like behaviors, but treatment with α-pinene at both doses reversed these anxiety-like behaviors in ketamine-treated mice; furthermore, the Forced Swim Test (FST) results revealed that ketamine-induced mice showed depressive-like behaviors, which were significantly reduced following treatment with α-pinene at a dose of 100 mg/kg.

A 2024 preclinical study used an early-life maternal separation chronic stress model in rats. Forty-nine Wistar rats were divided into seven groups, including two alpha-pinene treatment groups (5 and 10 mg/kg), a stress group, two combined treatment groups, and a positive control group (imipramine hydrochloride, 10 mg/kg). Alpha-pinene treatment at both doses significantly improved behavioral outcomes, reduced corticosterone levels, decreased MDA levels, and increased GPx activity in stressed rats, with effects comparable to imipramine.

It has been reported that inhalation of α-pinene causes anxiolytic effects on mice during the elevated plus maze test and antidepressant effects on rats in the forced swim test.

Evidence strength: Evidence is entirely preclinical (animal models). There are no human clinical trials evaluating α-pinene as an anxiolytic or antidepressant agent. Animal data is consistent across multiple models, but translation to human effects remains unvalidated.

4.5 Antimicrobial Activity

A wide range of pharmacological activities of α- and β-pinene have been reported, including antimicrobial effects. α-Pinene acts as an effective antibiotic agent, and shows some activity against MRSA. Regarding antibiotic resistance modulation, α-pinene has been used as an antibiotic resistance modulator for C. jejuni, acting on antibacterial resistance modulation and the prevention of antimicrobial efflux; it was shown to modulate antibiotic resistance considerably by reducing the MIC value of ciprofloxacin, erythromycin, and triclosan by up to 512 times.

Evidence strength: Antimicrobial activity data is primarily from in vitro microbiological assays. There are no published human clinical trials evaluating α-pinene as a standalone antimicrobial agent.

4.6 Anticancer Effects

Several in vitro and limited in vivo (animal) studies have examined anticancer properties of α-pinene.

In hepatocellular carcinoma: Alpha-pinene was identified as an active anti-proliferative compound on hepatoma carcinoma BEL-7402 cells using the MTT assay; further experiments showed that α-pinene inhibited BEL-7402 cells by arresting cell growth in the G2/M phase of the cell cycle, downregulating Cdc25C mRNA and protein expression, and reducing cyclin-dependent kinase 1 (CDK1) activity.

In ovarian cancer cell lines: In human ovarian cancer cells, α-pinene showed anticancer effect by cytotoxicity, cell cycle arrest (G2 to M phase), and apoptosis.

A particularly notable area of anticancer evidence involves α-pinene as a phytoncide and its connection to natural killer (NK) cell activity. A study in International Journal of Molecular Sciences (2021, PMC7826552) found that α-pinene activates NK cells and increases NK cell cytotoxicity, suggesting it is a potential compound for cancer immunotherapy. It has been well documented that "forest bathing" enhances human innate immune cell activity, especially in NK cells, by boosting the expression of anticancer proteins; this beneficial effect of forest bathing is known to be mainly due to phytoncides, aromatic volatile substances derived from trees.

In related human observational research, phytoncide exposure significantly increased NK activity and the percentages of NK, perforin, granulysin, and granzyme A/B-expressing cells, and significantly decreased the concentration of stress hormones adrenaline and noradrenaline in urine; phytoncides such as α-pinene and β-pinene were detected in the hotel room air, and these findings indicate that phytoncide exposure and decreased stress hormone levels may partially contribute to increased NK activity.

In a separate human observational study in female subjects, the forest bathing trip significantly increased NK activity and the numbers of NK, perforin, granulysin, and granzymes A/B-expressing cells and significantly decreased urinary stress hormones; the increased NK activity lasted for more than 7 days after the trip; phytoncides, such as alpha-pinene and beta-pinene, were detected in forest air; and these findings indicate that a forest bathing trip increased NK activity, number of NK cells, and levels of intracellular anti-cancer proteins in female subjects.

Evidence strength: Anticancer evidence for isolated α-pinene is predominantly in vitro and animal-based. The human NK cell data is derived from forest bathing studies involving mixed phytoncide exposures (not isolated α-pinene), limiting attribution of effects specifically to α-pinene. No controlled human clinical trials of isolated α-pinene as an anticancer intervention have been published.

4.7 Hepatoprotection

Alpha-pinene has been described as anti-oxidant, anti-inflammatory, anti-apoptotic, anti-diabetic, cardioprotective, and neuroprotective. Regarding liver protection specifically, alpha-pinene reduces liver enzyme levels of AST and ALT in diabetic rats, according to Santos et al. Moreover, alpha-pinene-containing plants like Myrtus communis L. and Rosmarinus officinalis L. are hepatoprotective.

Evidence strength: Hepatoprotective evidence is limited to preclinical (animal) studies. No human data exists for hepatoprotection by isolated α-pinene.

4.8 Sleep and Sedation

Alpha-pinene enhances the duration of non-rapid eye movement sleep, predominantly via the activation of GABA_A receptors. Multiple beneficial effects have been identified including sedative and anxiolytic properties.

Evidence strength: Preclinical only. No controlled human sleep studies of isolated α-pinene have been identified in the peer-reviewed literature.

5. Body Systems Associated with Alpha-Pinene

A wide range of pharmacological activities have been reported, including antibiotic resistance modulation, anticoagulant, antitumor, antimicrobial, antimalarial, antioxidant, anti-inflammatory, anti-Leishmania, and analgesic effects. The body systems most associated with α-pinene's studied activities include:

• Respiratory system: Bronchodilatory and expectorant effects via inhalation.
• Nervous system: Acetylcholinesterase inhibition, GABA_A receptor modulation, BDNF pathway upregulation, and neuroprotection.
• Immune system: NK cell activation and modulation of innate immune cytotoxicity via phytoncide exposure.
• Musculoskeletal/connective tissue: Anti-inflammatory and chondroprotective activity in osteoarthritis cell models.
• Hepatic (liver) system: Reduction of liver enzyme markers, suppression of fibrotic signaling pathways in animal models.
• Cardiovascular system: Anticoagulant and cardioprotective properties documented in preclinical studies.
• Skin/integumentary system: Topical antiseptic applications and documented contact sensitization risk.

6. Dosage Forms and Doses Reported in Studies

No standardized therapeutic dosage of isolated α-pinene has been established in humans. The following dosages were reported across specific research studies and should be understood strictly within their experimental contexts:

• Cognitive/Memory (rodent, intraperitoneal): Administration of α-pinene at 10 mg/kg (i.p.) significantly improved scopolamine-induced cognitive dysfunction as assessed by Y-maze and passive avoidance tests.
• Anxiety/Depression (rodent, intraperitoneal): Alpha-pinene at a dose of 100 mg/kg significantly reduced depressive-like behaviors in a ketamine-induced model of schizophrenia in mice.
• Antidepressant/Stress (rodent, unspecified route): Two alpha-pinene treatment groups at 5 and 10 mg/kg were studied alongside a positive control group of imipramine hydrochloride at 10 mg/kg in chronic stress rat models.
• Brain ischemia (rodent, intraperitoneal): Different doses of alpha-pinene (25, 50, and 100 mg/kg) were intraperitoneally injected immediately after reperfusion in male Wistar rats.
• Pain/Memory (rat, central administration): The effect on pain-induced memory impairment was blocked by α-pinene at the dose of 0.4 μg/rat.
• NK cell activity (in vitro): Human NK-92mi cells were treated with α-pinene at 100 µM in the context of phytoncide NK cell activation experiments.
• Dietary exposure (estimated): Exposure to α-pinene via a normal diet is estimated at 317 μg/day.

The volatility and hydrophobic nature of α-pinene (soluble in some organic solvents but not in aqueous conditions) seriously restrict the prevalence of its clinical use. Novel delivery systems such as lipid nanoparticles have been investigated to improve bioavailability for therapeutic purposes.

7. Safety Considerations and Interactions

Toxicity Profile — General

Alpha-pinene possesses low to moderate acute toxicity and is a known skin irritant and sensitizer; repeated inhalation exposure targets the liver, kidney (in rats), urinary bladder (in mice), and male reproductive system at concentrations relevant to occupational settings.

Skin Sensitization

Human studies indicate that alpha-pinene is a skin sensitizer; patch tests were conducted with 6 terpenes on 22 patients in Portugal, and a study which looked at the incidence of sensitization in workers using oil of turpentine was conducted. Investigators reported 24 cases of hand dermatitis in pottery workers involved in ceramic decoration, painters, liners, gilders, enamellers, and a fine china painter seen in a 6-month period; 14 were found to be sensitized to turpentine, 8 to alpha-pinene. Sensitization occurs mainly in painters, polishers, and varnishers, and in those in the perfume and ceramics industry.

Skin and Eye Irritation

The dermal LD50 for rabbit is greater than 5000 mg/kg; it causes skin irritation and serious eye irritation. α-Pinene is not expected to be phototoxic or photoallergenic based on phototoxicity/photoallergenicity evaluations.

Inhalation Hazard

α-Pinene elicited sensory irritation (stimulation of specific nerve endings in the nasolaryngeal region leading to characteristic "braking" during exhalation and a corresponding decrease in respiratory frequency) in a mouse bioassay, with a concentration that reduces respiratory rate by 50% (RD50) of 1,053 to 1,107 ppm for the more active D-α-pinene enantiomer.

While no specific Occupational Exposure Limit (OEL) exists for α-pinene in the US, limits are set for turpentine, which is primarily α-pinene; the ACGIH Threshold Limit Value (TLV) is 20 ppm and the OSHA Permissible Exposure Limit (PEL) is 100 ppm, both as an 8-hour time-weighted average.

Central Nervous System Effects at High Doses

Turpentine and the monoterpenes (alpha-pinene, beta-pinene, 3-carene) are skin and mucous membrane irritants, and in high concentrations, are central nervous system (CNS) depressants. Potential health effects at toxic doses include CNS depression and kidney damage.

Metabolite Concerns

The causality of α-pinene's toxicity is linked to its metabolites; assessing the genotoxic potential of the parent compound and its key metabolites (like α-pinene oxide) in a mammalian system with metabolic activation capability is a critical experimental step.

Carcinogenicity

According to IARC, NTP, ACGIH, OSHA, and Mexico's regulatory agencies, alpha-pinene is not listed as a carcinogen. Very little carcinogenicity data are available for α-pinene; two epidemiological studies have examined turpentine or terpene exposure in occupational settings and cancer outcomes.

Aspiration Hazard

Alpha-pinene is classified as an aspiration hazard Category 1, meaning aspiration of the liquid into the lungs (for example through vomiting after ingestion) represents a serious hazard.

Environmental Safety

Alpha-pinene is very toxic to aquatic life with long-lasting effects.

Interactions and Synergies

Synergistic interaction of α-pinene offers great potential in different therapeutic areas. Within the context of cannabis research and terpene pharmacology, α-pinene acts as an acetylcholinesterase inhibitor, is an effective antibiotic agent with some activity against MRSA, and is a bronchodilator in humans — properties that may act synergistically with cannabinoids. No specific adverse drug-drug interactions for isolated α-pinene supplementation have been identified in the clinical literature to date.

References

• Kim DS et al. (2015). Alpha-Pinene Exhibits Anti-Inflammatory Activity Through the Suppression of MAPKs and the NF-κB Pathway in Mouse Peritoneal Macrophages. PubMed PMID 26119957.
• Rufino AT et al. (2014). Anti-inflammatory and chondroprotective activity of (+)-α-pinene: structural and enantiomeric selectivity. Journal of Natural Products. PubMed PMID 24455984.
• Park BB, An JY, Park SU. (2021). Recent studies on pinene and its biological and pharmacological activities. EXCLI Journal. PMC8222632.
• Salehi B et al. (2019). Therapeutic Potential of α- and β-Pinene: A Miracle Gift of Nature. International Journal of Molecular Sciences. PMC6920849.
• Lee GY et al. (2017). Amelioration of Scopolamine-Induced Learning and Memory Impairment by α-Pinene in C57BL/6 Mice. Evidence-Based Complementary and Alternative Medicine. PMC5687139.
• Frontiers in Molecular Neuroscience. (2023). Alpha-pinene moderates memory impairment induced by kainic acid via improving the BDNF/TrkB/CREB signaling pathway in rat hippocampus. PMC10347414.
• IBRO Neuroscience Reports. (2024). Neuroprotective effects of alpha-pinene against behavioral deficits in ketamine-induced mice model of schizophrenia. PMC10839590.
• PMC. (2024). Behavioral and physiological benefits of alpha-pinene in adult rats experiencing chronic stress. PMC12702075.
• PMC. (2019). Attenuation Effects of Alpha-Pinene Inhalation on Mice with Dizocilpine-Induced Psychiatric-Like Behaviour. PMC6699265.
• PMC. (2022). α-Pinene Influence on Pulpal Pain-Induced Learning and Memory Impairment in Rats Via Modulation of the GABAA Receptor. PMC9482378.
• PMC. (2021). α-Pinene Enhances the Anticancer Activity of Natural Killer Cells via ERK/AKT Pathway. PMC7826552.
• Li Q et al. (2008). A forest bathing trip increases human natural killer activity and expression of anti-cancer proteins in female subjects. PubMed PMID 18394317.
• Li Q et al. (2009). Effect of Phytoncide from Trees on Human Natural Killer Cell Function. International Journal of Immunopathology and Pharmacology.
• Oncotarget. (2018). Health effects of a forest environment on natural killer cells in humans: an observational pilot study. PMC5893257.
• Chen WQ et al. (2014). Inhibitory effects of α-pinene on hepatoma carcinoma cell proliferation. Asian Pacific Journal of Cancer Prevention. PubMed PMID 24815485.
• Xu Q et al. (2018). α-pinene regulates miR-221 and induces G2/M phase cell cycle arrest in human hepatocellular carcinoma cells. Bioscience Reports. PMC6294613.
• Molecular Biology Reports. (2023). Alpha-pinene modulates inflammatory response and protects against brain ischemia via iNOS-NF-κB-COX-2 pathway.
• PMC. (2024). The protective effects of alpha-pinene on high glucose-induced oxidative stress and inflammation in HepG2 cells. PMC11193501.
• PMC. (2025). Alpha-pinene ameliorates liver fibrosis by suppressing oxidative stress, inflammation, and the TGF-β/Smad3 signaling pathway. PMC11831751.
• PMC. (2024). Alpha-Pinene-encapsulated lipid nanoparticles diminished inflammatory responses in THP-1 cells and imiquimod-induced psoriasis-like skin injury in mice. PMC11554515.
• PMC. (2021). Wound Healing Activity of α-Pinene and α-Phellandrene. PMC8123182.
• Phytochemistry. (2021). α-Pinene: A never-ending story. ScienceDirect.
• RSC Advances. (2022). The pinene scaffold: its occurrence, chemistry, synthetic utility, and pharmacological importance.
• Australian Government, Department of Health. Alpha-pinene: Human health tier II assessment.
• National Toxicology Program (NTP). Introduction — NTP Technical Report on the Toxicity Studies of α-Pinene (CASRN 80-56-8) Administered by Inhalation to F344/N Rats and B6C3F1/N Mice. NCBI Bookshelf.
• RIFM. RIFM fragrance ingredient safety assessment, α-pinene, CAS Registry Number 80-56-8.
• Wikipedia. α-Pinene.
• ScienceDirect Topics. Alpha-Pinene — an overview.